CTOs on the Move

Community Medical Center, Inc

www.communitymed.org

 
CMC's Department of Pediatrics and the hospital's administration are committed to quality care for children, said Steve Carlson, CMC's president and chief executive officer.
  • Number of Employees: 100-250
  • Annual Revenue: $50-100 Million

Executives

Name Title Contact Details

Similar Companies

Hologram Sciences

Reimagining the future of nutrition

Iberia Medical Center

Iberia Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Iberia Medical Center is based in New Iberia, LA. You can find more information on Iberia Medical Center at www.iberiamedicalcenter.com

Medavie EMS

Medavie EMS is a health care delivery and management company based in Dartmouth, Nova Scotia, Canada.  We have a team of management staff that specializes in the areas of project management, planning, education, human resources, communications finance, physical resources, process design, facilitation, reporting, and information technology.   Currently, Medavie EMS is responsible to deliver EMS in Nova Scotia, New Brunswick, Prince Edward Island, the District Municipality of Muskoka in Ontario, the Municipality of Chatham-Kent in Ontario, Elgin County in Ontario, Saskatoon and surrounding areas in Saskatchewan, as well as, communities across eastern Alberta.  Each of these systems is managed by subsidiary companies which have established contracts with governments (provincial and municipal) or health authorities.   In addition, Medavie EMS operates a patient transfer service in Massachusetts headquartered in Boston.  Combined these companies directly employ or manage a total staff of approximately 3800, 550 of whom are in the US.

NovaRx Corporation

NovaRx Corporation is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. NovaRx Corporation is based in San Diego, CA. You can find more information on NovaRx Corporation at www.novarx.com

Maverick Therapeutics

Maverick Therapeutics is pioneering the next generation of redirected T-cell targeted immunotherapies. Mavericks highly innovative platform, COBRA™, is the most advanced bispecific T-cell engaging platform in its class, designed to safely target solid tumors with highly specific and potent activity.